These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 26453149)

  • 1. In vitro synergy of penicillin, ceftriaxone and levofloxacin against serotype 19A Streptococcus pneumoniae.
    Tsai HY; Liao CH; Liu CY; Huang YT; Hsueh PR
    Int J Antimicrob Agents; 2015 Dec; 46(6):722-5. PubMed ID: 26453149
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro susceptibility of a penicillin-resistant and tolerable isolate of Streptococcus pneumoniae to combination therapy.
    Majhi A; Nandi A; Adhikary R; Mahanti S; Bishayi B
    J Infect Dev Ctries; 2015 Jul; 9(7):702-9. PubMed ID: 26230119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Levofloxacin-Resistant Multidrug-Resistant Streptococcus pneumoniae Serotype 11A Isolates, South Korea.
    Park M; Kim HS; Kim HS; Park JY; Song W; Cho HC; Kim JS
    Emerg Infect Dis; 2016 Nov; 22(11):1978-1980. PubMed ID: 27767906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in the antimicrobial susceptibilities and serotypes of Streptococcus pneumoniae: results from the Tigecycline In Vitro Surveillance in Taiwan (TIST) study, 2006-2010.
    Tsai HY; Chen YH; Liao CH; Lu PL; Huang CH; Lu CT; Chuang YC; Tsao SM; Chen YS; Liu YC; Chen WY; Jang TN; Lin HC; Chen CM; Shi ZY; Pan SC; Yang JL; Kung HC; Liu CE; Cheng YJ; Liu JW; Sun W; Wang LS; Ko WC; Yu KW; Chiang PC; Lee MH; Lee CM; Hsu GJ; Hsueh PR
    Int J Antimicrob Agents; 2013 Oct; 42(4):312-6. PubMed ID: 23849332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial susceptibility of multidrug-resistant Streptococcus pneumoniae strains with penicillin MICs of 8 to 32 mg/L.
    Rodríguez-Cerrato V; Gracia M; Del Prado G; Huelves L; Naves P; Ruiz V; Ponte C; Soriano F
    Diagn Microbiol Infect Dis; 2010 Mar; 66(3):336-8. PubMed ID: 19939599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ceftaroline Activity Against Multidrug-Resistant Streptococcus pneumoniae from U.S. Medical Centers (2014) and Molecular Characterization of a Single Ceftaroline Nonsusceptible Isolate.
    Pfaller MA; Mendes RE; Flamm RK; Jones RN; Sader HS
    Microb Drug Resist; 2017 Jul; 23(5):571-579. PubMed ID: 27918694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased ceftriaxone susceptibility in emerging (35B and 6C) and persisting (19A) Streptococcus pneumoniae serotypes in the United States, 2011-2012: ceftaroline remains active in vitro among β-lactam agents.
    Mendes RE; Biek D; Critchley IA; Farrell DJ; Sader HS; Jones RN
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4923-7. PubMed ID: 24867974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time-kill evaluation of antimicrobial regimens against clinical isolates of penicillin-resistant Streptococcus pneumoniae.
    Bañón Arias R; García López M; Pinedo Sánchez A
    J Chemother; 2001 Oct; 13(5):535-40. PubMed ID: 11760218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of ceftaroline against recent emerging serotypes of Streptococcus pneumoniae in the United States.
    Jacobs MR; Good CE; Windau AR; Bajaksouzian S; Biek D; Critchley IA; Sader HS; Jones RN
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2716-9. PubMed ID: 20308374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative activity of gatifloxacin and other antibiotics against 4009 clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000.
    White RL; Enzweiler KA; Friedrich LV; Wagner D; Hoban D; Bosso JA
    Diagn Microbiol Infect Dis; 2002 Jul; 43(3):207-17. PubMed ID: 12106954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ceftriaxone acts synergistically with levofloxacin in experimental meningitis and reduces levofloxacin-induced resistance in penicillin-resistant pneumococci.
    Flatz L; Cottagnoud M; Kühn F; Entenza J; Stucki A; Cottagnoud P
    J Antimicrob Chemother; 2004 Feb; 53(2):305-10. PubMed ID: 14729741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changing trends in serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae causing invasive diseases in Central Thailand, 2009-2012.
    Phongsamart W; Srifeungfung S; Chatsuwan T; Nunthapisud P; Treerauthaweeraphong V; Rungnobhakhun P; Sricharoenchai S; Chokephaibulkit K
    Hum Vaccin Immunother; 2014; 10(7):1866-73. PubMed ID: 25424794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fractional maximal effect method for in vitro synergy between amoxicillin and ceftriaxone and between vancomycin and ceftriaxone against Enterococcus faecalis and penicillin-resistant Streptococcus pneumoniae.
    Desbiolles N; Piroth L; Lequeu C; Neuwirth C; Portier H; Chavanet P
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3328-33. PubMed ID: 11709304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of the investigational ketolide cethromycin against macrolide- and penicillin-resistant Streptococcus pneumoniae: review of the 1998 to 2006 Canadian Respiratory Organism Susceptibility Study (CROSS).
    Wierzbowski AK; Karlowsky JA; Hoban DJ; Zhanel GG
    J Antimicrob Chemother; 2009 Mar; 63(3):620-2. PubMed ID: 19151038
    [No Abstract]   [Full Text] [Related]  

  • 15. Breakthrough in penicillin resistance? Streptococcus pneumoniae isolates with penicillin/cefotaxime MICs of 16 mg/L and their genotypic and geographical relatedness.
    Soriano F; Cafini F; Aguilar L; Tarragó D; Alou L; Giménez MJ; Gracia M; Ponte MC; Leu D; Pana M; Letowska I; Fenoll A
    J Antimicrob Chemother; 2008 Dec; 62(6):1234-40. PubMed ID: 18799472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005.
    Messina AF; Katz-Gaynor K; Barton T; Ahmad N; Ghaffar F; Rasko D; McCracken GH
    Pediatr Infect Dis J; 2007 Jun; 26(6):461-7. PubMed ID: 17529859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First reporting of the penicillin susceptibility of invasive Streptococcus pneumoniae isolates from the Northern Territory of Australia.
    Brischetto A; Baird R; Hennessy J
    Int J Antimicrob Agents; 2014 Sep; 44(3):278-9. PubMed ID: 25108875
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy of beta-lactams against experimental pneumococcal endocarditis caused by strains with different susceptibilities to penicillin.
    Pichardo C; Docobo-Pérez F; Pachón-Ibáñez ME; Jiménez-Mejías ME; García-Curiel A; Caballero-Granado FJ; Moreno-Maqueda I; Pachón J
    J Antimicrob Chemother; 2005 Oct; 56(4):732-7. PubMed ID: 16150863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changing trend in susceptibility pattern of Streptococcus pneumoniae to penicillin in India.
    Lalitha MK; Thomas K; Manoharan A; Song JH; Steinhoff MC
    Indian J Med Res; 1999 Nov; 110():164-8. PubMed ID: 10680301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome Evolution to Penicillin Resistance in Serotype 3 Streptococcus pneumoniae by Capsular Switching.
    Chiba N; Murayama SY; Morozumi M; Iwata S; Ubukata K
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630198
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.